Lifeward CEO Mark Grant Departs; Josh Hexter Named Interim CEO
LFWD sits 85% above its 52-week low of $4.14.
Summary
Lifeward announced the departure of CEO Mark Grant and the appointment of Josh Hexter as interim CEO, along with a new CFO, Rami Aviram, effective November 1, 2026.
Key Events · Executive and Board Changes · LFWD
-
CEO Mark Grant Departs
President and CEO Mark Grant left the company effective August 31, 2026, under a separation agreement with no cash severance; he will serve as a senior advisor through September 30, 2026 for a $40,000 consulting fee.
-
Interim CEO Appointed
Josh Hexter, COO and Business Officer of controlling shareholder Oramed Pharmaceuticals, was named interim CEO effective September 1, 2026, with a monthly salary of NIS 100,000 plus a NIS 5,000 commuting allowance.
-
New CFO Named
Rami Aviram was appointed CFO effective November 1, 2026, succeeding Almog Adar, whose departure was previously announced; Aviram will receive a monthly salary of NIS 70,000 plus a NIS 5,000 commuting allowance.
-
Leadership Overhaul Continues
This filing follows the August 14, 2026 resignation of three board members and the CFO, and the August 20, 2026 appointment of three new directors, indicating a broad restructuring of management and governance.
Analysis · LFWD · Industrial Applications And Services
Lifeward's CEO Mark Grant is out effective August 31, 2026, replaced on an interim basis by Josh Hexter, a senior executive at controlling shareholder Oramed Pharmaceuticals. The company also named Rami Aviram as CFO effective November 1, 2026, filling a vacancy created by the previously announced departure of Almog Adar. The leadership overhaul comes just weeks after three board members resigned and a going concern warning was reaffirmed, underscoring the urgency of stabilizing operations.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 29.9% of the 1591 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.24%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LFWD was trading at $7.65 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $21.7M. The 52-week trading range was $4.14 to $10.56. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.